Masimo (MASI) Free Cash Flow Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 93.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 93.52% |
| Jan 3, 2026 | 62.28% |
| Sep 27, 2025 | 127.05% |
| Jun 28, 2025 | 116.45% |
| Mar 29, 2025 | 135.58% |
| Dec 28, 2024 | -28.96% |
| Mar 30, 2024 | -7.62% |
| Sep 30, 2023 | -37.87% |
| Jul 1, 2023 | -38.15% |
| Apr 1, 2023 | -52.03% |
| Dec 31, 2022 | -33.96% |
| Oct 1, 2022 | -52.82% |
| Jul 2, 2022 | -33.80% |
| Apr 2, 2022 | -57.63% |
| Jan 1, 2022 | 37.73% |
| Apr 3, 2021 | -9.62% |
| Sep 26, 2020 | 89.00% |
| Jun 27, 2020 | 51.63% |
| Mar 28, 2020 | -17.43% |
| Dec 28, 2019 | -43.73% |
| Sep 28, 2019 | 13.87% |
| Jun 29, 2019 | -17.95% |
| Mar 30, 2019 | 38.18% |
| Dec 29, 2018 | -4.40% |
| Mar 31, 2018 | 229.42% |
| Sep 30, 2017 | -31.76% |
| Jul 1, 2017 | 9.20% |
| Apr 1, 2017 | -23.44% |
| Dec 31, 2016 | 320.41% |
| Oct 1, 2016 | 30.28% |
| Jul 2, 2016 | 84.14% |
| Apr 2, 2016 | -16.68% |
| Jan 2, 2016 | 62.91% |
| Apr 4, 2015 | -55.28% |
| Sep 27, 2014 | 9.11% |
| Jun 28, 2014 | -65.96% |
| Mar 29, 2014 | 11.28% |
| Dec 28, 2013 | -43.80% |
| Mar 30, 2013 | -12.03% |
| Sep 29, 2012 | 8.90% |